GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Gross Margin %

Tivic Health Systems (Tivic Health Systems) Gross Margin % : 1.40% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Tivic Health Systems's Gross Profit for the three months ended in Dec. 2023 was $0.01 Mil. Tivic Health Systems's Revenue for the three months ended in Dec. 2023 was $0.36 Mil. Therefore, Tivic Health Systems's Gross Margin % for the quarter that ended in Dec. 2023 was 1.40%.


The historical rank and industry rank for Tivic Health Systems's Gross Margin % or its related term are showing as below:

TIVC' s Gross Margin % Range Over the Past 10 Years
Min: -68.81   Med: -3.02   Max: 24.41
Current: 24.41


During the past 5 years, the highest Gross Margin % of Tivic Health Systems was 24.41%. The lowest was -68.81%. And the median was -3.02%.

TIVC's Gross Margin % is ranked worse than
85.18% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.335 vs TIVC: 24.41

Tivic Health Systems had a gross margin of 1.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Tivic Health Systems was 0.00% per year.


Tivic Health Systems Gross Margin % Historical Data

The historical data trend for Tivic Health Systems's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems Gross Margin % Chart

Tivic Health Systems Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
-68.81 -26.16 -3.02 16.25 24.40

Tivic Health Systems Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.54 30.05 37.89 38.30 1.40

Competitive Comparison of Tivic Health Systems's Gross Margin %

For the Medical Devices subindustry, Tivic Health Systems's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tivic Health Systems's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's Gross Margin % falls into.



Tivic Health Systems Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Tivic Health Systems's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.3 / 1.176
=(Revenue - Cost of Goods Sold) / Revenue
=(1.176 - 0.889) / 1.176
=24.40 %

Tivic Health Systems's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0 / 0.357
=(Revenue - Cost of Goods Sold) / Revenue
=(0.357 - 0.352) / 0.357
=1.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tivic Health Systems  (NAS:TIVC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tivic Health Systems had a gross margin of 1.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Tivic Health Systems Gross Margin % Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tivic Health Systems (Tivic Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Executives
Sheryle Bolton director 55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria director C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst director, officer: Chief Executive Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein officer: Chief Scientific Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia officer: Chief Operating Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach officer: Interim CFO 25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai officer: Chief Financial Officer C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude 10 percent owner 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz officer: Chief Financial Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025